Investigation into the clinical course and outcome of patients with GBS, identifying clinical and biological predictors of outcome as early as possible after onset of the neuropathy.
Investigation into the clinical course and outcome of patients with GBS, identifying clinical and biological predictors of outcome as early as possible after onset of the neuropathy.
To determine predictors of ultimate outcome in patients with Guillain Barre Syndrome (GBS).
Children (with adult consent) and adults are both eligible.
Patients with GBS or GBS variants including Miller Fisher Syndrome, identified within two weeks of onset of their weakness
None
Nicholas J. Silvestri, MD; Gil I. Wolfe, MD
Name: Kara Patrick
Phone: 716-859-4125
Email: kpatrick@buffalo.edu